- Home
- VALU vs KRRO Comparison
VALU vs KRRO Comparison
Compare VALU & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALU
- KRRO
- Stock Information
- Founded
- VALU 1931
- KRRO 2014
- Country
- VALU United States
- KRRO United States
- Employees
- VALU N/A
- KRRO N/A
- Industry
- VALU Investment Managers
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- VALU Finance
- KRRO Health Care
- Exchange
- VALU Nasdaq
- KRRO Nasdaq
- Market Cap
- VALU 366.3M
- KRRO 358.3M
- IPO Year
- VALU N/A
- KRRO 2019
- Fundamental
- Price
- VALU N/A
- KRRO $45.81
- Analyst Decision
- VALU
- KRRO Strong Buy
- Analyst Count
- VALU 0
- KRRO 7
- Target Price
- VALU N/A
- KRRO $96.71
- AVG Volume (30 Days)
- VALU 5.0K
- KRRO 231.6K
- Earning Date
- VALU 09-15-2025
- KRRO 11-11-2025
- Dividend Yield
- VALU 3.20%
- KRRO N/A
- EPS Growth
- VALU 6.17
- KRRO N/A
- EPS
- VALU 2.26
- KRRO N/A
- Revenue
- VALU $34,801,000.00
- KRRO $6,281,000.00
- Revenue This Year
- VALU N/A
- KRRO $116.91
- Revenue Next Year
- VALU N/A
- KRRO N/A
- P/E Ratio
- VALU $17.25
- KRRO N/A
- Revenue Growth
- VALU N/A
- KRRO N/A
- 52 Week Low
- VALU $32.94
- KRRO $10.29
- 52 Week High
- VALU $57.68
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- VALU 58.97
- KRRO 66.86
- Support Level
- VALU $38.33
- KRRO $43.41
- Resistance Level
- VALU $39.87
- KRRO $49.01
- Average True Range (ATR)
- VALU 0.65
- KRRO 4.33
- MACD
- VALU 0.15
- KRRO 0.25
- Stochastic Oscillator
- VALU 93.13
- KRRO 77.85
About VALU Value Line Inc.
Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and making available copyright data, including ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets under brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing and a trusted name in Investment Research. Its only operating segment being Publishing.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.